Jun 02, 2020 / 06:00PM GMT
Rajbir Singh Denhoy - Jefferies LLC, Research Division - MD, Equity Research & Senior Equity Research Analyst
Thank you, everyone, again, for joining us at the Jefferies 2020 Virtual Health Care Conference. Again, I'm Raj Denhoy with the Medical Vice Research team. Up next, we have Integra LifeSciences. And from the company, we have Mike Beaulieu, who does the company's Investor Relations as well as the company's President and CEO, Pete Arduini.
So first of all, thank you guys for joining us today. We have about 25 minutes, and we're going to do Q&A. If anybody has any specific questions they want to ask, they can e-mail me, and we'll try and fit them in, but it's pretty tight.
Questions and Answers:
Rajbir Singh Denhoy - Jefferies LLC, Research Division - MD, Equity Research & Senior Equity Research AnalystSo maybe, Pete, we can just start with kind of an overview of the business where it stands today. I know you've probably gotten asked this question a number of times over the last several weeks, and I don't want you to give an --